The Therapeutic Effects of Sevelamer on Blood Sugar, HbA1c, Lipid Profile, and hs-CRP in Patients with Diabetic Nephropathy
Background: Diabetic nephropathy (DN) is one of the major complications of diabetes. Hyperglycemia, inflammation and oxidative stress as well as advanced glycation end products (AGEs) are reported as the risk factors for DN. Sevelamer has shown promising results in reducing inflammation and even HbA...
Main Authors: | Sosan Mohammadi Kebar, Afshan Shargi, Bahman Bashardoust, Manouchehr Iranparvar, Hossein Fekri, Afshin Habibzadeh |
---|---|
Format: | Article |
Language: | English |
Published: |
Society of Diabetic Nephropathy Prevention
2018-04-01
|
Series: | Journal of Nephropathology |
Subjects: | |
Online Access: | https://nephropathol.com/PDF/jnp-7-65.pdf |
Similar Items
-
The effect of APN, hs-CRP and APN/hs-CRP in periodontitis with DAA
by: Rui Cheng, et al.
Published: (2023-02-01) -
Sevelamer-Induced Gastrointestinal Injury Presenting as Gastroenteritis
by: Jared Magee, et al.
Published: (2018-02-01) -
Evaluation of HS-CRP and Lipid Profile in COPD
by: Anup N. Nillawar, et al.
Published: (2013-05-01) -
Hyperhomocysteinemia, Insulin Resistance and High HS- CRP Levels in Prehypertension
by: Prashanth Talikoti, et al.
Published: (2014-08-01) -
Effect of sevelamer on serum phosphorus levels in chronic kidney disease and hemodialysis patients; a systematic review and meta-analysis
by: Farshad Gharebakhshi, et al.
Published: (2024-01-01)